Financials

News Ideas Discussions Technicals Seasonals

C2RS34 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of CRISPR THERADRN

Total assets of C2RS34 for Q2 24 is 13.12 B BRL, 7.07% more than the previous Q1 24. And total liabilities increased by 12.81% in Q2 24 to 2.01 B BRL.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: BRL

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—